MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Proposals to repeal LIFO
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M GANLEY | — |
Health Issues HCR
Incentive for health information technology, Affordable Care Act, proposed regulation of medical software, proposals to promote healthcare interoperability, and other healthcare policy issues. H.R. 6, 21st Century Cures Act; H.R. 2396, SOFTWARE Act, S. 1101, MEDTECH Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M GANLEY | — |
Veterans VET
Existing Department of Veterans' Affairs Pharmaceutical Prime Vendor Contract
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M GANLEY | — |
Medicare/Medicaid MMM
Physician and pharmacy reimbursement issues and implementation of the Affordable Care Act. H.R. 696 To amend Part B of title XVII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological under Medicare H.R. 2 Medicare Access and CHIP Reauthorization Act of 2015 H.R. 1416 Cancer Patient Protection Act of 2015 H.R. 2895, the Medicare Patient Access to Cancer Treatment Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT BROW | — |
| JOSEPH M GANLEY | — |
| BEN JONES New | — |
| KEAGAN R LENIHAN | — |
Pharmacy PHA
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion, H.R. 471 "Ensuring Patient Access and Effective Drug Enforcement Act of 2015", S. 483 "Ensuring Patient Access and Effective Drug Enforcement Act of 2015"
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M GANLEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.